BANKING & FINANCE - May 1, 1995
<i> Times Staff and Wire Reports</i>
Merck & Co. said it won clearance from the U.S. Food and Drug Administration to sell its Pepcid ulcer drug to treat heartburn and acid indigestion without a prescription, starting in June.
